Which patient groups are candidates for autologous stem cell transplant to treat multiple myeloma (MM)?

Updated: May 11, 2021
  • Author: Dhaval Shah, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

The first step before starting therapy in MM is to determine whether a patient is a candidate for an autologous stem cell transplant. Eligibility depends primarily on the patient’s age and comorbidities. Typically an age of 65 years is used as a cut-off point for transplant eligibility. Thus, treatment for MM is best looked at in terms of the following three categories of patients:

  • Young, newly diagnosed patients who are potential transplant candidates
  • High-risk patients who are potential transplant candidates
  • Newly diagnosed elderly patients who are not transplant candidates

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!